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Background: The risk of type 2 diabetes is increasing in teenage girls, and is associated with
their greater insulin resistance (IR).
Hypothesis: We hypothesized that the adverse metabolic profile of girls (compared with boys)
would persist from childhood through adolescence.
Patients and Methods: Community-based longitudinal cohort of 292 children (147 boys) stud-
ied annually from 9 to 16 years. Measures: IR (homeostasis-model-assessment-2), high-density
lipoprotein-cholesterol (HDL-C), triglycerides, % body-fat (dual-energy x-ray absorptiometry),
pubertal stage (age at peak height velocity), physical activity (accelerometry). Multi-level model-
ling established the age-related trends in IR and lipids and the influence of covariates.
Results: Each year from 9 to 15 years, girls had 21% to 63% higher IR than boys (girls mean IR
0.73-1.33, boys 0.51-0.89, P < .005). At 16 years the gender difference was not significant
(girls IR 0.60, boys 0.56, P = .45). Girls had lower HDL-C from 9 to 12 years, higher triglycer-
ides from 9 to 14 years, greater adiposity throughout, and earlier puberty, but boys were more
active than girls (all P < .05).
After adjustment for %-fat, puberty and activity, the gender difference in IR between girls and
boys aged 9 to 15 years became non-significant (IR girls 0.66-1.01, boys 0.65-1.04, P > .07).
However, after adjustment at 16 years, girls’ IR was 25% lower than boys’ (girls 0.44, boys
0.63, P = .001), and they had 22% higher HDL-C (P < .001) and 20% lower triglycer-
ides (P = .003).
Conclusions: The higher IR of prepubertal and early pubertal girls diminishes during late
puberty, and boys begin to exhibit greater metabolic risk. Despite being leaner and more active,
boys at 16 years have higher IR than girls, suggesting future higher risk for diabetes, thus we
reject our hypothesis.
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1 | INTRODUCTION
Type 2 diabetes (T2D) is presenting at increasingly younger ages, and
the diagnosis is often made in the teenage years.1 T2D in children
has become a serious public health concern, and in some high-risk
populations it is now more common than type 1 diabetes.2 The risk
of T2D in this age group is strongly associated with obesity2; 92% of
children with T2D have been reported as overweight or obese.3
According to a large recent study from North America, T2D prev-
alence was 0.58 per 1000 in girls and 0.35 per 1000 in boys,4 and
other studies have reported a female excess of T2D among children
and adolescents.3,5,6 These observations contrast with findings in
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adults, where men are reported to be at higher risk than women.7,8
The explanation for the gender difference in the prevalence of T2D
between adults and adolescents is uncertain, however, it has been
proposed that endocrine changes leading to pubertal insulin resist-
ance (IR) may be among the factors influencing the risk of T2D in
children.9 There may be a “cross-over” of the gender difference in IR
between childhood and adulthood, with a decline in IR in postpuber-
tal females relative to males. These changes could reflect age- and
gender-dependent changes in adiposity. Logue et al10 reported that
men develop T2D at a lower body mass index (BMI) than women,
and suggested this was because men are more insulin resistant and
have more central fat than women.
Cross-sectional studies at birth11 and throughout the prepubertal
years12,13 have consistently shown higher fasting insulin concentra-
tions in females. These have also been observed in longitudinal stud-
ies during adolescence.14,15 The EarlyBird longitudinal study has
previously reported higher levels of IR in 5-year-old girls compared
with boys, even after accounting for differences in adiposity and
physical activity.16 Moreover, it is well established that puberty is
associated with a substantial increase in IR.17,18 Gender differences
in IR have been attributed to differences in adiposity, fat distribution,
sex hormones, and pubertal timing.19,20 The temporal influence of dif-
ferent factors can only be investigated with longitudinal studies. Ear-
lyBird is a unique longitudinal study of the same children over a
period of 12 years. Gender differences from 5 to 8 years have been
reported previously.16 The aim of this analysis was to investigate gen-
der differences in IR between 9 and 16 years. We hypothesized that
the adverse metabolic profile of girls (compared with boys) would
persist from childhood through adolescence.
2 | PATIENTS AND METHODS
2.1 | Design, setting, and participants
EarlyBird is a non-intervention longitudinal cohort study of 347 chil-
dren (174 boys and 173 girls) recruited from 53 primary schools in Ply-
mouth, UK. Exclusion criteria were diabetes, pathological states likely
to affect growth or body composition, moderate or severe physical
disability, and long-term use of oral steroids. A total of 307 children
were recruited at 5 years in 2000 to 2001 and 40 more at age 9 years
in 2004 to 2005 to redress a gender imbalance. Most were white Cau-
casian (n = 342) and 5 children (3 girls, 2 boys, 1.5% of the cohort)
were of mixed race, reflecting the racial mix of the city (98.4% white
Caucasian according to the 2001 census).21 Children were seen annu-
ally (mean interval 1.0 year, SD 0.1). Assent from the child at each visit
and written consent from the parent were obtained. Ethical approval
was granted by the Local Research Ethics Committee in 1999 and
updated regularly. The study has been reported in detail elsewhere.22
2.2 | Main outcome measure
IR was measured by homeostasis model assessment-2 method using
the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
program, downloaded from the University of Oxford Diabetes Trials
Unit website (www.dtu.ox.ac.uk).23 A venous blood sample was taken
at 9 AM after an overnight fast. Serum insulin was measured by Immu-
lite analyser (Diagnostic Products Corporation, Los Angeles, Califor-
nia), cross-reactivity with proinsulin <1%, inter-assay coefficient of
variation (CV) 9%, detection limit of the assay 2.0 mU/L (14 pmol/L).
Glucose was measured using Cobas Integra 700 analyser (Roche
Diagnostics GmbH, Mannheim, Germany; inter-assay CV 2%).
HOMA-IR has been validated against the euglycemic clamp (r = 0.91)
in healthy youths.24
2.3 | Secondary outcome measures
High-density lipoprotein-cholesterol (HDL-C) and triglycerides were
measured using Cobas Integra 700 analyser (Roche Diagnostics) and
inter-assay CV 2%.
2.4 | Predictor variables
Gender, age, height measured to nearest 1 mm (Leicester Height
Measure, Child Growth Foundation, London),weight measured to
nearest 200 g (Tanita Solar 1632W electronic scales, West Drayton,
London, UK), and BMI standard deviation scores (SDS) were calcu-
lated25; waist circumference were measured by metal tape (Chasmors
Ltd, London, UK); body fat (% fat) was measured annually by dual
energy x-ray absorptiometry (DEXA) by Prodigy Advance fan beam
densitometer (GE Healthcare, Chicago, Illinois, USA).
Pubertal status measured by age at peak height velocity (APHV),
determined as the tangential velocity at the middle time-point of
3 consecutive height measurements taken 6 months apart. APHV, an
objective measure of puberty, allows comparison of pubertal devel-
opment between genders.26,27
Physical activity was measured by Actigraph accelerometers
(Model 7164, Fort Walton Beach, Florida), having good technical
reproducibility.28 Accelerometers were worn around the waist and
recorded continuously for 7 days each year. The children wore the
accelerometer every day from getting up until going to bed, removing
it only for water-based activities, and keeping a diary of any activity
undertaken while not wearing the accelerometer. Only recordings
capturing at least 4 days of monitoring (each incorporating at least
9 hours’ wear time, and including at least 1 weekend day) were
included in the analyses. Time spent in moderate-and-vigorous inten-
sity physical activities (MVPA; min/wk) was calculated against the
threshold specific to 3 metabolic equivalents of task (METs), deemed
by the UK Government to be the lower limit of moderate activity.29
Children's MVPA varied little from 9 to 16 years,30 and in order
to characterize the overall long-term physical activity level of each
child, their MVPA was averaged across all 8 time points. In doing so,
the children were ranked according to their activity levels throughout
the whole period with 95% reliability, compared with 70% reliability
when using 1 annual measure of physical activity.30
2.5 | Statistical analysis
The distributions of HOMA-IR, triglycerides, % fat, and MVPA, were
skewed in both genders and were log-transformed for analysis and
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back-transformed for presentation. Cross-sectional analyses were
performed using IBM SPSS version 22 (IBM Corp., Armonk,
New York). The gender difference between mean values was
expressed as a percentage. Differences between individuals were
assessed by independent t tests. Univariate regression explored the
association between the outcome variable and predictor variables.
Longitudinal data were analyzed using linear mixed-effects mod-
elling taking into account all available data at each time-point
(R software31 using lmer function in lme432). The effect of covariates
on the gender difference in IR over time was examined. Random
intercepts were included as well as age (categorized to allow for non-
linear change in IR over time), gender, % fat, APHV, and MVPA as
fixed effects. Two-way interactions between the covariates, age, and
gender were examined and retained in the model if significant at the
5% level or of particular interest. Interpretation of the model coeffi-
cients was facilitated by plotting.
3 | RESULTS
A total of 292 children (147 boys) had measures of IR at 9 years (84%
of the cohort), and these subjects were used for this analysis. Descrip-
tive characteristics are shown in Table 1. The girls attained peak
height velocity 1.64 years before boys. Girls had significantly higher %
body fat at each age, larger waist circumferences from 10 years
onwards, and a significantly higher BMIsds at 14 years (P = .003).
IR rose and fell through puberty in both genders, with boys
reaching peak IR at 14 years, and girls at 12 years. IR was signifi-
cantly higher in girls than boys at each age up to 15 years, with the
biggest gender difference at 12 years. Girls had 13% to 18% higher
triglycerides than boys from 9 to 14 years (P < .032), but the differ-
ence was no longer significant at 15 and 16 years. Boys had 3% to
7% higher HDL-C than girls from 9 to 12 years (P < .02), whereas by
15 years girls had 7% higher HDL-C (P = .02), and by 16 years girls
were 9% higher (P < .001).
3.1 | Univariate regression
Predictor variables were added separately at each age to assess their
contribution to IR (Table S1, Supporting Information). The variable
having the greatest effect on the gender difference in IR was % fat.
After adjusting for fat there was no significant gender difference in IR
at ages 9 to 11, 14, and 15 years. At 12 and 13 years, girls were still
more insulin resistant than boys after accounting for fat (P < .001
and .018 respectively), and at 16 years, girls were 40% less insulin
resistant than boys (P < .001). Waist circumference, BMI, APHV, and
MVPA each had more modest effects in attenuating the gender dif-
ference in IR. When these variables were included in the models, girls
remained more insulin resistant than boys throughout.
Adjusting for % fat, APHV and MVPA increased the gender dif-
ference in HDL-C levels at 16 years, with % fat having the greatest
effect (girls 25% higher than boys; P < .001). The only predictor varia-
ble which influenced the gender difference in triglycerides at
16 years was % fat, adjusting for which led to girls having 20% lower
levels than boys (P < .001).
Fasting glucose levels were significantly higher in the boys than
girls at 10 years and 13 to 16 years. The gender difference in glucose
was explained by APHV at 14 and 15 years, but adjusting for adipos-
ity and MVPA made little difference.
3.2 | Longitudinal modelling
The measure of adiposity explaining the greatest proportion of the
gender difference in IR was total % fat, therefore this was included as
a covariate in the longitudinal models along with objective measures
of APHV and MVPA, as these are also known to influence IR.
Figure 1 shows mean (95% confidence interval [CI]) IR in boys and
girls from 9 to 16 years. Figure 1A shows the unadjusted IR (model
estimates are given in Table S2). Figure 1B shows IR adjusted for APHV
alone, Figure 1C shows IR adjusted for APHV and MVPA, and
Figure 1D shows IR adjusted for APHV, MVPA, and % fat. The inclu-
sion of all 3 covariates in the model affected the gender difference in
IR such that there was a cross-over between 13 and 14 years so that
by 16 years, IR in girls was approximately 25% lower than in boys.
Figure 2 shows the mean (95% CI) HDL-C and triglycerides in
boys and girls from 9 to 16 years. Figure 2A (raw data) shows that
HDL-C fell from 9 to 16 years, with the fall more marked in boys.
After adjustment (Figure 2B), HDL-C became significantly higher in
the girls from 12 years onwards such that by 16 years, HDL-C was
approximately 22% higher in girls than boys (Table S3). Triglycerides
increased in both genders, girls having 13% to 18% higher levels than
boys from 9 to 14 years (raw data, Figure 2C). However, after adjust-
ment for % fat, APHV and MVPA, there was no gender difference in
triglycerides until 16 years when the girls had approximately 20%
lower levels than boys (Figure 2D; Table S4).
4 | DISCUSSION
The principal finding of this study was that IR is significantly higher in
adolescent girls than boys, and this gender difference narrows and
reverses by age 16 years, at which age boys become more insulin
resistant than girls. After adjusting for factors known to influence IR,
the gender difference in IR between 9 and 15 years was largely
attributable to differences in adiposity. Furthermore, these findings
were largely mirrored by changes in levels of triglycerides and HDL-C
levels, which support the likely biological significance of the temporal
changes in IR.
Fasting glucose levels were slightly higher in boys, and this gen-
der difference was attenuated to some extent by pubertal stage, and
not by adiposity or activity. Relatively higher glucose in boys at
16 years (by 4%) could have contributed to their higher adjusted IR
at 16 years, but is unlikely to have affected their lipids.
This analysis extends the findings of Moran et al,14 who studied
350 children aged 11 to 15 years at baseline, with 55% cohort reten-
tion at 18 to 19 years. In that study IR was higher in girls at 11 years,
and higher in boys at 19 years. However, the authors did not find
any association between pubertal development and IR. Our longitudi-
nal dataset with 8 measurements at annual time points, 93% cohort
retention for measures of IR, and the small age range of the
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TABLE 1 Cohort characteristics
Boys Girls
B vs G
n Mean SD n Mean SD P
Age at 9 y visit (years) 147 8.87 0.29 145 8.83 0.32 .495
Index of Multiple Deprivation at 9 y 146 24.59 13.74 145 23.39 14.85 .475
Age at peak height velocity (years) 122 13.27 0.87 127 11.63 1.17 <.001
BMI (SDS)
9 y 147 0.36 1.15 145 0.59 1.09 .075
10 y 144 0.43 1.13 141 0.63 1.17 .135
11 y 144 0.32 1.20 140 0.57 1.21 .078
12 y 144 0.42 1.23 138 0.66 1.20 .087
13 y 137 0.46 1.20 127 0.74 1.23 .059
14 y 134 0.37 1.17 128 0.80 1.17 .003
15 y 121 0.40 1.16 114 0.65 1.09 .097
16 y 135 0.41 0.25 128 0.75 1.13 .019
Waist circumference (SDS)
9 y 146 0.44 1.11 143 0.63 1.23 .173
10 y 144 0.55 1.06 140 0.84 1.25 .039
11 y 142 0.54 1.07 134 0.96 1.28 .003
12 y 139 0.53 1.05 128 1.00 1.32 .001
13 y 136 0.54 1.04 127 1.08 1.33 <.001
14 y 134 0.48 0.99 128 1.15 1.30 <.001
15 y 133 0.46 0.96 127 1.07 1.32 <.001
16 y 135 0.48 1.08 128 1.07 1.36 <.001
HDL cholesterol (mg/dL)a
9 y 147 72.70 15.08 145 68.06 14.69 .007
10 y 143 71.93 15.85 142 67.67 14.69 .019
11 y 141 68.45 15.47 141 63.42 13.92 .004
12 y 139 65.35 14.69 133 60.71 13.53 .006
13 y 139 59.17 14.31 133 57.23 13.15 .339
14 y 134 55.68 13.15 131 56.07 11.60 .651
15y 134 52.20 11.21 133 55.68 11.60 .018
16 y 139 50.27 11.21 135 54.91 11.21 <.001
Boys Girls
B vs G
n Median IQR n Median IQR P
Insulin resistance (unit)
9 y 147 0.54 0.33-0.81 145 0.76 0.53-1.03 <.001
10 y 138 0.78 0.53-1.04 142 0.97 0.69-1.33 .005
11 y 141 0.72 0.46-1.10 141 0.98 0.69-1.52 <.001
12 y 139 0.90 0.58-1.23 132 1.36 0.92-1.96 <.001
13 y 138 0.89 0.63-1.34 133 1.38 0.92-1.80 <.001
14 y 134 0.93 0.57-1.37 131 1.31 0.88-1.66 <.001
15 y 135 0.77 0.51-1.23 133 1.09 0.69-1.56 .001
16 y 138 0.62 0.23-1.04 133 0.67 0.23-1.09 .446
Triglycerides (mg/dL)b
9 y 147 46.06 36.3-59.3 145 55.80 36.3-59.3 .001
10 y 143 49.60 38.1-66.4 142 56.68 38.1-66.4 .006
11 y 141 51.37 40.7-68.2 141 62.88 40.7-68.2 .001
12 y 139 54.03 39.9-76.2 133 64.66 39.9-76.2 .005
13 y 139 57.57 42.5-83.3 133 66.43 42.5-83.3 .01
14 y 134 62.00 44.3-79.7 131 70.86 44.3-79.7 .032
15 y 135 53.14 44.3-70.9 133 62.00 44.3-70.9 .118
16 y 139 62.00 44.3-79.7 135 62.00 44.3-79.7 .939
(Continues)
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participants has allowed us to identify more precisely the age at
which this gender reversal in IR occurs. The use of linear mixed-
effects models allowed incorporation of all covariates and repeated
measures simultaneously.
Moran et al14 did not examine the influence on IR of age-
dependent changes in adiposity. Changes in IR occur against a back-
ground of body fat levels that are declining in boys and increasing in
girls. These changes reflect increasing lean body mass and falling
body fat as boys develop adult male body composition. It appears
contradictory that IR falls in girls while they continue to gain fat mass.
Despite these different patterns, the association between IR and %
fat remained stronger in girls. This may be of pathophysiological sig-
nificance, with relevance to the excess risk of T2D in adolescent
females.
The raw data results for triglycerides and HDL-C support the
observations of Dai et al33 who studied 3 cohorts of children meas-
ured 3 times in 1 year. For both measures, girls’ triglycerides were
higher and HDL-C lower between 8 and 11 years, but had reversed
by 14 years. Our fully adjusted trends over 8 annual time-points are
able to pinpoint the ages at which this cross-over occurs. There is
TABLE 1 (Continued)
Boys Girls
B vs G
n Median IQR n Median IQR P
DEXA fat (%)
9 y 141 16 11-23 143 24 19-32 <.001
10 y 143 19 12-27 143 27 21-34 <.001
11 y 136 20 13-29 128 28 22-36 <.001
12 y 138 22 15-29 128 28 22-36 <.001
13 y 138 20 14-30 132 29 23-36 <.001
14 y 137 18 13-26 128 31 27-38 <.001
15 y 117 16 12-23 110 33 28-38 <.001
16 y 132 16 11-26 126 34 29-38 <.001
MVPA (min/wk)
9 y 137 413 293-526 135 282 215-362 <.001
10 y 132 353 243-469 133 261 193-340 <.001
11 y 130 341 273-469 126 228 165-304 <.001
12 y 121 380 260-506 123 237 168-306 <.001
13 y 123 380 248-542 127 248 167-306 <.001
14 y 128 330 222-499 115 205 151-313 <.001
15 y 107 343 207-463 99 207 131-268 <.001
16 y 99 314 178-436 106 194 117-285 <.001
Abbreviations: B, boys; DEXA, dual energy x-ray absorptiometry; G, girls; HDL-C, high-density lipoprotein-cholesterol; IQR, interquartile range; MVPA,
moderate-and-vigorous intensity physical activity; SDS, standard deviation score.
a To convert HDL-C from mg/dL to mmol/L divide by 38.67.
b To convert triglycerides from mg/dL to mmol/L divide by 88.57.
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)FIGURE 1 Insulin resistance (mean, 95%
confidence interval [CI]) in children from
9 to 16 years according to gender. A,
Unadjusted; B, adjusted for age at peak
height velocity (APHV); C, adjusted for
APHV and moderate-and-vigorous
intensity physical activity (MVPA); D,
adjusted for APHV, MVPA, and % fat
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clear divergence of HDL-C from 12 years onwards and of triglycer-
ides from 15 years onwards. The HDL-C data are in line with the nor-
mative data collected by the Caliper study,34 showing slightly higher
levels in girls from 13 to 19 years, and no gender difference in triglyc-
eride levels.
The gender differences observed in metabolic variables could be
explained by changes in fat distribution, with boys accumulating more
central adiposity, known to be associated with increased IR and dia-
betes risk, and girls accumulating more subcutaneous and/or gluteal
adiposity. However, waist circumference-SDS increased significantly
in the girls from 9 to 16 years but did not change in the boys, sug-
gesting that the girls were accumulating excess abdominal fat, while
boys were growing at the expected rate. Despite this potential mask-
ing effect of excess weight gain in girls, we report a cross-over in the
gender difference in IR and lipids. Therefore, we are unable to explain
the observed gender differences in IR and lipids by changes in body
composition. Further studies using direct measures of visceral adipos-
ity could clarify this issue.
Another possibility is that peripubertal changes in IR are influ-
enced by changing sex-steroid concentrations. The postpubertal
decline in IR in girls might be related to rising oestrogen concentra-
tions; oestrogen has several insulin-sensitizing effects.35 Alternatively,
rising androgen levels in both genders could affect IR. Testosterone
has been shown to decrease insulin sensitivity in both men and
women.36 However, levels of sex hormone-binding globulin, which
are strongly influenced by adiposity and IR in childhood,37 modulate
the bioavailability of estradiol and testosterone so that increasing adi-
posity augments free concentrations of sex steroids. Therefore, while
sex steroids may influence IR, there is a complex and probably bidi-
rectional interrelationship.
Growth hormone and the growth axis are also important deter-
minants of IR during puberty. The association plays an important
physiological role, as the acceleration of growth during puberty is
achieved in an energy-efficient manner mediated, at least in part,
through hyperinsulinaemia/IR.38,39 The different reproductive desti-
nies of each sex place different biological imperatives—with different
tempos—on vertical growth and the acquisition of fat.
Physical activity is a potential factor that could influence meta-
bolic health in adolescence, and may be highly relevant to diabetes
and cardiovascular disease prevention strategies in young people.
Physical activity declines during adolescence,40 and while there was
considerable inter-individual variation in activity levels at each time
point, intra-individual activity remained remarkably stable. Ranking
the participants according to their 8-year activity levels allowed maxi-
mum precision, yet the overall contribution of activity to the gender
difference in IR and lipids was modest.
We have previously shown that physical activity attenuates the
mid-adolescent peak in IR and that this effect disappears by 16 years,
independent of adiposity and pubertal stage.30 In our final model,
however, physical activity explained only a small proportion of the
gender difference in IR. Whether or not a modest increase in physical
activity in high risk teenagers reduces their risk of T2D remains
uncertain.
These findings may have practical relevance for early interven-
tions designed to prevent or delay the onset of T2D in young people.
It can be suggested that the excess risk of T2D in girls may be
explained by their greater IR, although it is unclear how this is associ-
ated with beta cell failure. Weight gain between 9 and 16 years, a
key influence on IR, is a potential target for intervention. Whether or
not IR and other characteristics at puberty can predict subsequent
hyperglycaemia will require longer term follow-up of the cohort.
This study has strengths and limitations. EarlyBird is a well-
established longitudinal cohort study with high retention and criterion
measures of IR, fatness, and activity. The narrow age range and multi-
ple repeated measures allow for within- and between-subject com-
parisons. Longitudinal modelling uses all the available data while
accommodating missing data points, and our methods allowed for
retention of subjects in analyses despite some missing data points.
Inevitably, some data is missing over an 8-year study, particularly
measures of MVPA at later ages, and reliability was maximized by cal-
culating a mean value over 8 years. Although pubertal stage was not
directly assessed, APHV is a well-established objective surrogate for
direct assessment of pubertal stage. It was unfeasible to take more
than 1 fasting measure from the children each year, thus insulin was
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FIGURE 2 Lipid levels (mean, 95% age at
peak height velocity [CI]) in children from
9 to 16 years according to gender. A, High-
density lipoprotein-cholesterol (HDL-C)
unadjusted; B, adjusted for % fat, age at
peak height velocity (APHV) and moderate-
and-vigorous intensity physical activity
(MVPA); C, triglycerides unadjusted; D,
adjusted for % fat, APHV, and MVPA
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measured from a single sample rather than the mean of 3. HOMA is a
surrogate measure of IR, but, correlating strongly with results from
clamp studies, it is the most appropriate measure to use in young
children. Accelerometry is a robust measure of physical activity,
although limitations include the potential to miss upper body move-
ment and the fact that they must be removed for water-based activ-
ities. Activity diaries reduced some of these limitations. The EarlyBird
cohort is mainly Caucasian, and results may not be generalizable to
populations with different ethnic composition. The current analysis
terminates at 16 years when the metabolic effects of puberty may
persist, especially in boys. Follow-up to adulthood will confirm
whether IR remains higher in postpubertal males compared with
females, before and after adjustment for adiposity, and whether IR is
associated with increased long-term risk for the development of T2D.
We conclude that the higher IR of prepubertal and early pubertal
girls appears to be largely explained by their greater fat mass, with
more modest effects of physical activity and the timing of puberty.
Around the age of 16 years a “cross-over” point is reached when,
despite their lower fat mass and higher activity levels, boys become
more insulin resistant than girls, and have higher triglycerides and
lower HDL-C levels. The changing risk factors for boys and girls will
inform diabetes prevention strategies in children.
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